Cancer Specific Services
-
Manufactured by Creative Peptidesbased in USA
Epitope Mapping is an essential aspect in the discovery and development of diagnostic and therapeutic antibodies. It can aid in the selection of optimized therapeutic MAbs, elucidate cancer-specific epitope markers, and define the protective (and in some cases pathogenic) effects of vaccines. Based on our advanced peptide library ...
-
based in CHINA
Cancer is a complicated disease caused by genetic variation. The genetic variation may deprive cells of the normal control function, leading to immortalization and cancer. And targeted drugs work well in cancer therapy, which can kill cancer cells that carry specific genes of variation. However, patients may ...
-
Manufactured by Ulisse BioMedbased in ITALY
Ulisse BioMed proposes a specific offer for the detection and genotyping of Human Papillomavirus (HPV) to physicians and professionals in the gynecological ...
-
by SonALAsensebased in USA
We are committed to providing hope in the face of despair with a unique proprietary non-invasive drug-device combination therapy, ALA Sonodynamic Therapy (SDT), for the treatment of recurrent glioblastoma multiforme (rGBM). ...
-
based in USA
LiquidHALLMARK® is an ultrasensitive next-generation sequencing assay for genomic profiling of a patient’s unique cancer. By requiring only a single blood sample, LiquidHALLMARK provides important information for cancer care especially when tissue by invasive biopsy is insufficient or ...
-
based in AUSTRALIA
Cell therapy is the transfer of intact, live cells into a patient to help lessen or cure a disease. The most common and simple type of cell therapy is a blood transfusion. Other commonly known cell therapies include red and white blood cell transfusions and bone marrow ...
-
based in UNITED KINGDOM
Viewing cancer through the immune lens (immuno-oncology) has led to the most promising advancements in cancer treatment in recent history, nonetheless the full potential of the approach is as yet ...
-
based in CANADA
mutations, and mutations with prognostic and diagnostic implications for care. Find It helps oncologists to tailor treatments based on the genomic mutations in their patients’ tumors for more personalized cancer ...
-
based in USA
Auspex Diagnostic’s colorectal cancer test is a revolutionary treatment planning tool that can help stage II and III colorectal cancer patients and doctors personalize the treatment to the individual patient’s genes. Since no two patients are the alike, it is crucial that patients learn as much as possible about their ...
-
based in USA
Cytogenetics is the study of normal and abnormal chromosomes in relation to disease. Sometimes called chromosome analysis or karyotyping, cytogenetic tests are used to gain diagnostic and prognostic insights regarding solid tumor cancers and hematologic malignancies, which can be the result of chromosome rearrangements or altered chromosome ...
-
based in UNITED KINGDOM
EarlyCDT is a simple blood test that detects the elevated presence of autoantibodies generated by the body's immune system as a natural defence against cancer cells. EarlyCDT Lung is the world’s most thoroughly validated blood test for the detection of lung cancer and requires only a small volume of blood which can be taken in the ...
-
Manufactured by Data Driven Diagnostic Sciences (D3Sciences)based in USA
Detecting, Diagnosing and Treating Cancer: To detect, diagnose, and treat internal cancer requires a team of healthcare providers led generally by three specialist physicians: oncologists, radiologists, and pathologists. Upon examining a patient, and assessing the indicators for the presence of the disease, the oncologist ...
-
Manufactured by Mesothelioma + Asbestos Awareness Centerbased in USA
There is no cure for mesothelioma, but clinical trials and experimental treatments offer hope for the future. In the never-ending effort to eradicate cancer, there are medical and scientific researchers constantly looking for new ways to attack this deadly disease. Many of the commonly used methods of treating cancer today were once ...
-
based in CANADA
While tissue samples are the standard for cancer molecular profiling, tissue can often be challenging to obtain. Surgical biopsy may be risky or impossible, the biopsy procedure may have resulted in insufficient or exhausted tissue, or the sample acquired resulted in poor quality DNA. Whatever the reason, plasma assays can provide a less ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you